关注
Federica Martorana
Federica Martorana
Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi di Catania
在 unict.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
L Gerratana, D Basile, G Buono, S De Placido, M Giuliano, S Minichillo, ...
Cancer treatment reviews 68, 102-110, 2018
2452018
AKT inhibitors: new weapons in the fight against breast cancer?
F Martorana, G Motta, G Pavone, L Motta, S Stella, SR Vitale, L Manzella, ...
Frontiers in pharmacology 12, 662232, 2021
1452021
Molecular alterations in thyroid cancer: from bench to clinical practice
E Tirrò, F Martorana, C Romano, SR Vitale, G Motta, S Di Gregorio, ...
Genes 10 (9), 709, 2019
922019
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery
S Di Franco, P Bianca, DS Sardina, A Turdo, M Gaggianesi, V Veschi, ...
Nature communications 12 (1), 5006, 2021
522021
Activation of the IGF axis in thyroid cancer: implications for tumorigenesis and treatment
L Manzella, M Massimino, S Stella, E Tirrò, MS Pennisi, F Martorana, ...
International journal of molecular sciences 20 (13), 3258, 2019
442019
Prognostic and therapeutic roles of the insulin growth factor system in glioblastoma
E Tirrò, M Massimino, C Romano, F Martorana, MS Pennisi, S Stella, ...
Frontiers in Oncology 10, 612385, 2021
332021
Opportunities and challenges of liquid biopsy in thyroid cancer
C Romano, F Martorana, MS Pennisi, S Stella, M Massimino, E Tirrò, ...
International journal of molecular sciences 22 (14), 7707, 2021
282021
Radiomics in cervical and endometrial cancer
L Manganaro, GM Nicolino, M Dolciami, F Martorana, A Stathis, ...
The British journal of radiology 94 (1125), 20201314, 2021
252021
Biomarkers and prognostic factors for malignant pleural mesothelioma
P Vigneri, F Martorana, L Manzella, S Stella
Future oncology 11 (24s), 29-33, 2015
252015
PI3K inhibition in breast cancer: Identifying and overcoming different flavors of resistance
SR Vitale, F Martorana, S Stella, G Motta, N Inzerilli, M Massimino, E Tirrò, ...
Critical reviews in oncology/hematology 162, 103334, 2021
232021
A new kid on the block: sacituzumab govitecan for the treatment of breast cancer and other solid tumors
G Pavone, L Motta, F Martorana, G Motta, P Vigneri
Molecules 26 (23), 7294, 2021
222021
Everything comes with a price: the toxicity profile of DNA-damage response targeting agents
F Martorana, LA Da Silva, C Sessa, I Colombo
Cancers 14 (4), 953, 2022
192022
Health-related quality of life in breast cancer patients treated with CDK4/6 inhibitors: a systematic review
V Di Lauro, G Barchiesi, F Martorana, G Zucchini, M Muratore, ...
ESMO open 7 (6), 100629, 2022
142022
Targeting the DNA damage response: PARP inhibitors and new perspectives in the landscape of cancer treatment
S Genta, F Martorana, A Stathis, I Colombo
Critical Reviews in Oncology/Hematology 168, 103539, 2021
142021
Phase I dose-escalation study of the dual PI3K-mTORC1/2 inhibitor gedatolisib in combination with paclitaxel and carboplatin in patients with advanced solid tumors
I Colombo, S Genta, F Martorana, M Guidi, M Frattini, EP Samartzis, ...
Clinical Cancer Research 27 (18), 5012-5019, 2021
112021
Molecular analysis of luminal androgen receptor reveals activated pathways and potential therapeutic targets in breast cancer
S Stella, SR Vitale, M Massimino, G Motta, C Longhitano, K Lanzafame, ...
Cancer Genomics & Proteomics 19 (4), 464-476, 2022
102022
A systematic review of phase II trials exploring anti-PD-1/PD-L1 combinations in patients with solid tumors
F Martorana, I Colombo, G Treglia, S Gillessen, A Stathis
Cancer Treatment Reviews 101, 102300, 2021
92021
Mutational Analysis of BRCA1 and BRCA2 Genes in Breast Cancer Patients from Eastern Sicily
S Stella, SR Vitale, F Martorana, M Massimino, G Pavone, K Lanzafame, ...
Cancer management and research, 1341-1352, 2022
72022
Type 2 diabetes and cancer: problems and suggestions for best patient management
A Milluzzo, P Vigneri, F Martorana, R Vigneri, L Sciacca
Exploration of Medicine 1 (4), 184-204, 2020
72020
Giant paratesticular liposarcoma: molecular characterization and management principles with a review of the literature
G Pavone, C Romano, F Martorana, L Motta, L Salvatorelli, AM Zanghì, ...
Diagnostics 12 (9), 2160, 2022
52022
系统目前无法执行此操作,请稍后再试。
文章 1–20